Onita Bhattasali

@KP_LAMC Radiation Oncology Residency APD ⚡️ | @KPMedSchool Assistant Professor and Radiation Oncology Clerkship Director | @UCBerkeley Alumna 🐻

[PDBrown @PDBrownOnc]

For meningioma does fSRS compare favorably to SRS?
· Yes despite signif larger tumors
· Good F/U (median 8 yrs)
· 613 Gr1 tumors
https://t.co/32o8TllCkG

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Hot🔥off🔥the🔥press
No difference in LC observed between #SRS #FSRS or #FSRT in over 600 benign intracranial meningiomas treated with frameless #LINAC based treatment 🧠⚡️☢️
@KPSCalResearch @KPMedSchool @KPResidencySCal @WorldNeurosurg
https://t.co/cqQ9fTxAIk

[Hyunsoo Joshua No, MD, CMD @DoctorNoMD]

I completed my last day of residency this past week @StanfordRadOnc. I have had the most fortunate life with unbelievable support and care from an innumerable number of people. My 3 incredible kids and tireless, amazing wife cheered me along every step of the way for which I am eternally grateful for as I heartily look forward to a career where I can provide that same level of support and care for those needing treatment for cancer.

[Onita Bhattasali @bhattasaliMD]

@KaiserRadOncRes @KPSCALnews @KPResidencySCal @RadoncMD Danny did a great job discussing the patterns of failure for definitively managed H&N salivary duct carcinoma and the impact of ipsilateral neck LN burden on contralateral neck recurrence @RadiumSociety @KPSCalResearch @KPMedSchool

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Postcards from ARS 2024. Here's Dr. Danny Vazquez (PGY-5) showcasing oral AND poster presentations. You makes us all so proud! #ars2024 #radonc @KPSCALnews @KPResidencySCal

[Michael R. Girvigian, M.D. @GirvigianMD]

Grand Opening of our newest radiation oncology department in Bellflower, CA!

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Dr. Yazeed Kesbeh (PGY-4) discussing cardiac ablation for atrial fibrillation at #2024RSS @the_RSS @KPSCALnews @KPSCalResearch ❤️ ⚡️

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Dr. Adam Beighley (PGY-3) rocked his oral presentation on brainstem mets treated with LINAC-based SRS at RSS2024 @the_RSS! @KPSCALnews @KPResidencySCal @ARRO_org #radonc #srs #rss

[Henry S. Park, MD, MPH @HenryParkMD]

Thank you for the invitation! I very much enjoyed spending time with your engaging faculty and residents.

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

An absolute blast with Dr. Paul Brown @PDBrownOnc today as our visiting professor @KaiserRadOncRes! Plenty to learn about brain met management, neuro-cognition, career advice, and work-life balance. @MayoClinic @KPSCALnews

[Onita Bhattasali @bhattasaliMD]

Great listening to @ZHusainMD help kick off #ASTRO23 this morning at the PRO session discussing locally advanced #larynxcancer
Tons of helpful tips and important considerations! @KaiserRadOncRes @aboutKP @ASTRO_org

[Onita Bhattasali @bhattasaliMD]

@KaiserRadOncRes @GirvigianMD @flash__80 Missing @mzhiMD !!

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Our SRS group excited to be in Munich for #BrainlabNovalisCircle

[Onita Bhattasali @bhattasaliMD]

Fantastic review of systemic therapy developments for brain metastases from @BrainTumorDoc at #BrainlabNovalisCircle
@Brainlab @BaptistHealthSF

[Onita Bhattasali @bhattasaliMD]

@DrEmmaHolliday @pre_rad This is everything… my door holders: @RadoncMD @SbrtSean @DrEmmaHolliday 🥹

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Congratulations to Dr. Joan Ryoo and colleagues for this paper highlighting how management within an integrated health care system mitigates SES-related mortality differences in colon cancer 👏🏽👏🏽👏🏽
https://t.co/oiFBUNmzyx
@KPMedSchool @KPSCalResearch @KP_LAMC

[Ming Zhi @mzhiMD]

Class of 2022-2023. 🙌👏🫶. #radonc #kaiser @KPSCALnews @KP_LAMC

[Onita Bhattasali @bhattasaliMD]

We previously published a retrospective comparison of triweekly carboplatin and high-dose cisplatin and found that triweekly carboplatin performed favorably for stage I-II but had inferior outcomes for stage III HPV+ disease:
https://t.co/4Bk055Dq7R
@KPSCalResearch

[Onita Bhattasali @bhattasaliMD]

We need to investigate better options for our cisplatin-ineligible H&N patients post-RTOG 1016 and NRG HN004. @RadoncMD gave an oral presentation at #ARS2023 today on our retrospective study suggesting superiority of triweekly carboplatin (AUC=5) over cetuximab:

[Kaiser Radiation Oncology Residency @KaiserRadOncRes]

Maui wow-ie! PGY-4 Derek Go gave an amazing oral presentation on our watch-and-wait rectal cancer pt outcomes at #ARS2023. He just received a $50k grant to further his work 🌟. Can’t wait to see what he is going to do next. @KP_LAMC #radonc #kaiser